VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF) , a clinical-stage biotech company dedicated to developing neurorestorative ...
A team of Japanese researchers reports that two out of four patients who received stem cell transplants showed improvements in motor function, marking a potential breakthrough in the treatment of ...
AZoLifeSciences on MSN5d
Can Tissue Engineering and Regenerative Medicine Reverse Spinal Cord Injuries?Advances in tissue engineering offer hope for spinal cord injury repair, utilizing biomaterials, stem cells, and bioactive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback